Literature DB >> 26511746

UK asbestos imports and mortality due to idiopathic pulmonary fibrosis.

C M Barber1, R E Wiggans2, C Young3, D Fishwick2.   

Abstract

BACKGROUND: Previous studies have demonstrated that the rising mortality due to mesothelioma and asbestosis can be predicted from historic asbestos usage. Mortality due to idiopathic pulmonary fibrosis (IPF) is also rising, without any apparent explanation. AIMS: To compare mortality due to these conditions and examine the relationship between mortality and national asbestos imports.
METHODS: Mortality data for IPF and asbestosis in England and Wales were available from the Office for National Statistics. Data for mesothelioma deaths in England and Wales and historic UK asbestos import data were available from the Health & Safety Executive. The numbers of annual deaths due to each condition were plotted separately by gender, against UK asbestos imports 48 years earlier. Linear regression models were constructed.
RESULTS: For mesothelioma and IPF, there was a significant linear relationship between the number of male and female deaths each year and historic UK asbestos imports. For asbestosis mortality, a similar relationship was found for male but not female deaths. The annual numbers of deaths due to asbestosis in both sexes were lower than for IPF and mesothelioma.
CONCLUSIONS: The strength of the association between IPF mortality and historic asbestos imports was similar to that seen in an established asbestos-related disease, i.e. mesothelioma. This finding could in part be explained by diagnostic difficulties in separating asbestosis from IPF and highlights the need for a more accurate method of assessing lifetime occupational asbestos exposure. © Crown copyright 2015.

Entities:  

Keywords:  Asbestos; asbestosis; idiopathic pulmonary fibrosis; mesothelioma.

Mesh:

Substances:

Year:  2015        PMID: 26511746      PMCID: PMC4757753          DOI: 10.1093/occmed/kqv142

Source DB:  PubMed          Journal:  Occup Med (Lond)        ISSN: 0962-7480            Impact factor:   1.611


  24 in total

1.  An expert system for the evaluation of historical asbestos exposure as diagnostic criterion in asbestos-related diseases.

Authors:  A Burdorf; P Swuste
Journal:  Ann Occup Hyg       Date:  1999-01

2.  Diagnosis and initial management of nonmalignant diseases related to asbestos.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2004-09-15       Impact factor: 21.405

3.  Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

Authors:  Paul W Noble; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Marilyn K Glassberg; David Kardatzke; Talmadge E King; Lisa Lancaster; Steven A Sahn; Javier Szwarcberg; Dominique Valeyre; Roland M du Bois
Journal:  Lancet       Date:  2011-05-13       Impact factor: 79.321

4.  Exposure-response relationship between chrysotile exposure and mortality from lung cancer and asbestosis.

Authors:  Qian Deng; Xiaorong Wang; Mianzheng Wang; Yajia Lan
Journal:  Occup Environ Med       Date:  2011-07-08       Impact factor: 4.402

5.  Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis.

Authors:  R Hubbard; S Lewis; K Richards; I Johnston; J Britton
Journal:  Lancet       Date:  1996-02-03       Impact factor: 79.321

Review 6.  Interstitial lung disease induced by exogenous agents: factors governing susceptibility.

Authors:  B Nemery; A Bast; J Behr; P J Borm; S J Bourke; P H Camus; P De Vuyst; H M Jansen; V L Kinnula; D Lison; O Pelkonen; C Saltini
Journal:  Eur Respir J Suppl       Date:  2001-09

Review 7.  Genetics and early detection in idiopathic pulmonary fibrosis.

Authors:  Rachel K Putman; Ivan O Rosas; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

Review 8.  Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005.

Authors:  Bertram Price; Adam Ware
Journal:  Crit Rev Toxicol       Date:  2009       Impact factor: 5.635

9.  Asbestosis mortality in the USA: facts and predictions.

Authors:  V C dos Santos Antao; G A Pinheiro; J T Wassell
Journal:  Occup Environ Med       Date:  2008-11-18       Impact factor: 4.402

10.  The rising incidence of idiopathic pulmonary fibrosis in the U.K.

Authors:  V Navaratnam; K M Fleming; J West; C J P Smith; R G Jenkins; A Fogarty; R B Hubbard
Journal:  Thorax       Date:  2011-04-27       Impact factor: 9.139

View more
  5 in total

1.  Estimating Lifetime Asbestos Exposure in Patients With Idiopathic Pulmonary Fibrosis.

Authors:  Christopher M Barber; Ruth E Wiggans; David Fishwick
Journal:  Ann Occup Hyg       Date:  2016-04-12

2.  Idiopathic pulmonary fibrosis and occupational risk factors.

Authors:  Silvia Ranzieri; Elisa Illica Magrini; Paola Mozzoni; Roberta Andreoli; Giovanna Pelà; Giuseppina Bertorelli; Massimo Corradi
Journal:  Med Lav       Date:  2019-12-17       Impact factor: 1.275

3.  Mortality from idiopathic pulmonary fibrosis: a temporal trend analysis in Brazil, 1979-2014.

Authors:  Eduardo Algranti; Cézar Akiyoshi Saito; Diego Rodrigues Mendonça E Silva; Ana Paula Scalia Carneiro; Marco Antonio Bussacos
Journal:  J Bras Pneumol       Date:  2017 Nov-Dec       Impact factor: 2.624

4.  Asbestosis is prevalent in a variety of construction industry trades.

Authors:  G I Walters; A S Robertson; P S Bhomra; P S Burge
Journal:  NPJ Prim Care Respir Med       Date:  2018-04-03       Impact factor: 2.871

5.  Asbestos Consumption in Mongolia: 1996-2014.

Authors:  Naransukh Damiran; Arthur Frank
Journal:  Int J Environ Res Public Health       Date:  2018-01-15       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.